Locations:
Search
by Saqib Sachani, PhD, MBA, Director, Innovations Business Development and Licensing
By Mohamed Ramadan, PhD, MBA, General Manager, Cleveland Clinic Innovations Development
Cleveland Clinic developed Autism Eyes, an eye-tracking technology that detects autism markers by analyzing how children view images. Acquired in early 2024, this technology aims to reduce the typical one-to-three-year delay between noticing symptoms and receiving a formal autism diagnosis.
Cleveland Clinic Innovations (CCI) demonstrated exceptional performance in 2024, securing 144 patents, generating $27 million in licensing revenue, and investing $29 million in companies. The organization's achievements spanned technology development, international expansion, and capital raises, solidifying its position as a transformative force in healthcare innovation.
LifeArc and Cleveland Clinic sign 10-year Master Services Agreement to develop novel monoclonal antibody-based therapeutics, building on their successful collaboration since 2019. The agreement combines LifeArc's three decades of expertise in antibody humanization with Cleveland Clinic's renowned capabilities, aiming to address unmet medical needs in areas including cancer and complement-mediated diseases.
In Cleveland Clinic Innovations’ latest Inventor Chronicle, discover how the Structured Innovation Challenge team "Sac it to ‘Em", featuring Linda Bradley, MD, Bradley Gill, MD, Cara King, DO, MS, Lindsey Valentine, MD, Liron Bar-El, MD, and Emily Frisch, MD, is streamlining specimen bagging with a revolutionary device that enhances efficiency and patient care.
Cleveland Clinic physicians Matthew Kroh, MD, Xiaoxi (Chelsea) Feng, MD, MPH, and Ricard Corcelles, MD, share how their Structured Innovation Challenge team, The Abdominal Innovators, which also included Salvador Navarrete, MD, and Andrew Strong, MD, are revolutionizing surgical precision with their work on a minimally invasive measurement instrument, as featured in Cleveland Clinic Innovations’ Inventor Chronicle series.
By Gerald “Jerry” Wilmink, PhD, MBA, Director, Innovations Business Development and Licensing
By Stephen MacNamara, MS, Associate Director, Innovations Development, Cleveland Clinic
